Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) provided a status report today on Mino-Lok® and CITI-002.Mr. Myron Holubiak, CEO of Citius, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE